China Tian Yuan Healthcare Group Limited (HK:0557)
:0557
Want to see HK:0557 full AI Analyst Report?
0557 Stock Chart & Stats
HK$0.70
-HK$0.10(-14.71%)
At close: 4:00 PM EST
HK$0.70
-HK$0.10(-14.71%)
Day’s Range― - ―
52-Week RangeHK$0.10 - HK$1.00
Previous CloseN/A
Volume26.00K
Average Volume (3M)3.33K
Market Cap
HK$183.53M
Enterprise ValueHK$194.51M
Total Cash (Recent Filing)HK$29.51M
Total Debt (Recent Filing)HK$38.72M
Price to Earnings (P/E)―
Beta-0.69
Next Earnings
Aug 31, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.08
Shares Outstanding398,979,520
10 Day Avg. Volume1,000
30 Day Avg. Volume3,326
Financial Highlights & Ratios
PEG Ratio14.09
Price to Book (P/B)1.73
Price to Sales (P/S)14.56
P/FCF Ratio30.63
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Manageable LeverageA debt-to-equity ratio near 0.20–0.24 signals a conservative capital structure that reduces refinancing and interest-rate risk. Over the next several months this financial flexibility supports operations while the company addresses profitability issues and enables targeted investment or restructuring without immediate solvency pressure.
Positive Free Cash FlowSustained positive operating and free cash flow in 2023–2025 shows the business can generate cash despite accounting losses. Durable cash generation permits working-capital needs, selective capex, and reduced dependency on external financing, providing a practical cushion as management pursues stability or turnaround actions.
High Gross MarginsGross margins above ~50% indicate strong unit economics or favorable cost structure at the product/service level. This structural margin advantage gives room to absorb SG&A reductions or scale benefits and means achieving operating profitability is plausible if top-line deterioration is arrested and overheads are controlled.
Bears Say
Revenue ContractionA ~27% revenue decline in 2025 and levels materially below 2021 indicate durable top-line weakness. Persistent contraction erodes scale, reduces pricing/negotiating leverage, and worsens fixed-cost absorption, making margin recovery harder and constraining investment in customer retention or product development over the medium term.
Persistent Operating And Net LossesRepeated negative EBIT/EBITDA and net losses show the company fails to convert gross profit into operating profitability. Chronic operating losses deplete equity, limit reinvestment capacity, and force reliance on cash buffers or financing, restricting strategic options and increasing long-term execution risk absent structural fixes.
Declining Equity And Negative ROEROE deteriorating to roughly -21% and falling equity reflect persistent value erosion. This weakens shareholder capital, can raise the cost or limit the availability of new capital, and undermines investor confidence, reducing the firm's ability to fund growth initiatives or absorb further shocks over the coming months.
China Tian Yuan Healthcare Group Limited News
0557 FAQ
What was China Tian Yuan Healthcare Group Limited’s price range in the past 12 months?
China Tian Yuan Healthcare Group Limited lowest stock price was HK$0.10 and its highest was HK$1.00 in the past 12 months.
What is China Tian Yuan Healthcare Group Limited’s market cap?
China Tian Yuan Healthcare Group Limited’s market cap is HK$183.53M.
When is China Tian Yuan Healthcare Group Limited’s upcoming earnings report date?
China Tian Yuan Healthcare Group Limited’s upcoming earnings report date is Aug 31, 2026 which is in 100 days.
How were China Tian Yuan Healthcare Group Limited’s earnings last quarter?
China Tian Yuan Healthcare Group Limited released its earnings results on Mar 30, 2026. The company reported -HK$0.078 earnings per share for the quarter, missing the consensus estimate of N/A by -HK$0.078.
Is China Tian Yuan Healthcare Group Limited overvalued?
According to Wall Street analysts China Tian Yuan Healthcare Group Limited’s price is currently Overvalued.
Does China Tian Yuan Healthcare Group Limited pay dividends?
China Tian Yuan Healthcare Group Limited does not currently pay dividends.
What is China Tian Yuan Healthcare Group Limited’s EPS estimate?
China Tian Yuan Healthcare Group Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does China Tian Yuan Healthcare Group Limited have?
China Tian Yuan Healthcare Group Limited has 398,979,520 shares outstanding.
What happened to China Tian Yuan Healthcare Group Limited’s price movement after its last earnings report?
China Tian Yuan Healthcare Group Limited reported an EPS of -HK$0.078 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of China Tian Yuan Healthcare Group Limited?
Currently, no hedge funds are holding shares in HK:0557
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
China Tian Yuan Healthcare Group Limited Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
37.93%
12-Months-Change
Fundamentals
Return on Equity
-33.69%
Trailing 12-Months
Asset Growth
-13.78%
Trailing 12-Months
Company Description
China Tian Yuan Healthcare Group Limited
China Tian Yuan Healthcare Group Limited, an investment holding company, provides healthcare related services in Hong Kong, Korea, and the People's Republic of China. It operates through Investment Holding, Healthcare, Money Lending and Related Business, and Hospitality segments. The company offers procurement, marketing, and management services to the medical industry; and plastic surgery services, as well as licenses trademarks. It also invests in equity investments and marketable equitable equity mutual funds; offers loans and related services; introduces lenders and borrowers; and provides procurement services to hospitality industry. The company was formerly known as City e-Solutions Limited and changed its name to China Tian Yuan Healthcare Group Limited in November 2017. The company was incorporated in 1990 and is based in Wan Chai, Hong Kong. China Tian Yuan Healthcare Group Limited is a subsidiary of Tian Yuan Manganese Limited.
Technical Analysis
Shun Ho Property Investments Ltd
―
Century City International Holdings Limited
―
Paliburg Holdings Limited
―
Regal Hotels International Holdings Limited
―
ITC Properties Group Limited
―